Clinical Trial Results: Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH [Phase 4]

View source ↗

Summary

Phase 4 trial results on riociguat evaluating effects on right ventricular size and function in patients with primary pulmonary arterial hypertension and chroni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension
• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• Riociguat (riociguat)

Snippet

Sponsor: Heidelberg University | Conditions: Primary Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2026-06-17